Search
Ensysce Biosciences Inc
ENSCAdd to Watchlist
0.260USD
+0.003+0.97%
Close 07-31 16:00（ET）Quotes delayed by 15 min
2.41MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-31No earnings forecast score is currently available for Ensysce Biosciences Inc. The Biotechnology & Medical Research industry's average is 8.14. The average price target is 26.23, with a high of 34.00 and a low of 18.45.
Analyst Rating
Based on
0
analysts
--
Current Rating
16.450
Target Price
+6407.12%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
496
Total
6
Median
7
Average
Company name
Ratings
Analysts
Ensysce Biosciences Inc
ENSC
0
Beigene Ltd
ONC
27
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
26
Ionis Pharmaceuticals Inc
IONS
25
Insmed Inc
INSM
23
1
2
3
...
99
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Ensysce Biosciences Inc's expected revenue for the next quarter?
Ensysce Biosciences Inc's expected revenue is 1.90M.
What is Ensysce Biosciences Inc's price target?
Analysts forecast that Ensysce Biosciences Inc's price target is USD 26.23, with the highest forecast at USD 34.00 and the lowest forecast at USD 18.45.
How have Ensysce Biosciences IncENSC's recent earnings per share performed?
The market expectation was USD -0.52, while Ensysce Biosciences IncENSC's earnings per share (EPS) for the previous quarter was USD -0.74. EPS for the next quarter is expected at USD -0.50.